Ipca Laboratories Ltd (BOM:524494)
₹ 1556.65 -0.9 (-0.06%) Market Cap: 394.93 Bil Enterprise Value: 400.86 Bil PE Ratio: 68.48 PB Ratio: 6.24 GF Score: 91/100

Q3 2020 IPCA Laboratories Ltd Earnings Call Transcript

Feb 13, 2020 / 05:30AM GMT
Release Date Price: ₹710.2 (+7.05%)
Operator

Ladies and gentlemen, good day, and welcome to the Ipca Laboratories Q3 FY '20 Conference Call hosted by IDFC Securities. (Operators Instructions)

Please note that this conference is being recorded. I now hand the conference over to Mr. Nirmal Gopi from IDFC Securities. Thank you, and over to you, sir.

Nirmal Ambattuparambil Gopi
IDFC Securities Limited, Research Division - Research Analyst

Thanks, Ayesha. Good morning, everyone, and a very warm welcome to Ipca Lab's Q3 FY '20 Earnings Call hosted by IDFC Securities.

On the call today, we have representing IPCA management, Mr. A. K Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company Secretary.

I hand over the call to the IPCA management team to make some opening comments, and then we'll open the floor for questions. Please go ahead, sir.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Thank you, Nirmal. Good afternoon. Thanks for taking out time and joining

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot